What Is/Juvenile Diabetes/St. Petersburg/Researching Type 1 Diabetes
St. Petersburg is rich with museums and galleries. In Dr. Carter G. Woodson African American Museum you can experience the historic voice of one segment of the St. Petersburg community in the perspective of local, regional, and national history. The museum joins Mercy Hospital at the Johnnie Ruth Clarke Health Center, the Royal Theater Boys and Girls Club, and the renovated Manhattan Casino as evidence of the commitment to revitalize the Midtown St. Petersburg area. Florida Holocaust Museum honoring the memory of millions of innocent men, women, and children who suffered or died in the Holocaust, the museum is dedicated to teaching members of all races and cultures to recognize the inherent worth and dignity of human life in order to prevent future genocides. Video Credit List is stored here http://broadcaster.beazil.net/public/credits/youtube/videos/41789 Type 1 diabetes is an auto-immune condition in which the immune system is activated to destroy the cells in the pancreas which produce insulin. We do not know what causes this auto-immune reaction. Type 1 diabetes is not linked to modifiable lifestyle factors. There is no cure and it cannot be prevented.
Type 1 diabetes:
– Occurs when the pancreas does not produce insulin
– Represents around 10% of all cases of diabetes and is one of the most common chronic childhood conditions
– Onset is usually abrupt and the symptoms obvious
– Symptoms can include excessive thirst and urination, unexplained weight loss, weakness and fatigue and blurred vision
– Is managed with insulin injections several times a day or the use of an insulin pump.
JDRF is the leading diabetes foundation funding T1D research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D. JDRF is currently sponsoring $530 million in scientific research in 17 countries. In 2012 alone, JDRF provided more than $110 million to T1D research. JDRF’s goal is a world without type 1 diabetes (T1D). Our plan is to create a future where:
– Your blood glucose levels can be controlled automatically
– You can sleep, eat, exercise, and live as if T1D is not in your life
– T1D can be cured and is no longer present in your body
– T1D can be prevented and never threaten anyone again. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It seems important to point out the main points –
Bolus Basel,TRIAD Results,T1D Staging,diabetes advocacy,Derek Rapp,NIDDM,diabetes distress,very-low-density lipoprotein cholesterol,glycemic control,b-cell destruction,Countdown,Bag of Hope,Cost of insulin,insulin body site rotation,insulin resistance,insulin aspart,make a donation,proinsulin,insulin adjustment,biguanide,Carb Counting,JDRF One Walk,DKA,engage,diabetes prevention program,injection site rotation,ketone,Daily Living,Prevention of diabetes complications,insulin-independent glucose,T1D Community,tolazamide,NRTIs,Glucagon-like peptide 1 agonists,implantable insulin pump,neonatal diabetes,IGT,Ketoacidosis,funding research,insulin pen,The Action to Control Cardiovascular Risk in Diabetes Study,Veterans Affairs Diabetes Trial,Type 1 Diabetes,SGLT2 inhibitors,low-density lipoprotein cholesterol,blood pressure,Blood Glucose Level,GLP-1 agonists,50/50 insulin,Low Blood Sugar,treatment,Diabetes and Pregnancy,TypeOneNation,no insulin production,worldwide effort,Fla,Long Acting Insulin,LADA,Diet,triglyceride,insulin therapy,help,low blood glucose,diabetes management,ketonuria,diabetic retinopathy,Novolin R,Prevent.